資源 » 參考數據庫 » 客戶發(fā)表文獻

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫(yī)藥類雜志引用近萬次，處于行業(yè)領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發(fā)表科研成果，再次證明GenScript 有能力幫助業(yè)內科學家Make research easy.

Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal.

Cancer Manag Res. 2018;

YinXiteng，WeiZheng，SongChuanhui，TangChuanchao，XuWenguang，WangYufeng，XieJunqi，LinZitong，Ha

Products/Services Used	Details	Operation
Recombinant Proteins	Protein samples were mixed with 5× loading buffer (GenScript, Nanjing, China) and heated at 95°C for 10 minutes.	Get A Quote

摘要

The objectives of this study were to explore the mechanisms of metformin sensitization to hypoxia-induced gefitinib treatment in resistant head and neck squamous cell carcinoma (HNSCC) and evaluate the effects of this combined treatment strategy.